Haoxi Health Technology Co., Ltd. (HAO) - Amount of Cash per Share

Haoxi Health Technology revenues rely on the marketing budgets of the Chinese healthcare sector. Changes in cash per share confirm the impact of this dependency, where 17.95 represents the current metric. The stability of this narrow niche is constrained by Beijing's strict control, while risks are amplified by the potential loss of major contracts with pharma behemoths and a general economic downturn in the region.
Analytical breakdowns for Haoxi Health Technology (HAO)

For Haoxi Health Technology (HAO), which integrates autonomous AI agents into media buying, liquidity availability is critical when scaling technologies. This cash cushion per share is calculated by dividing the total cash volume by the number of issued securities. The trend of this metric reflects the company's actual ability to fund expansion without external borrowing. Rising values confirm the strengthening of the business's fundamental resilience, while a stable cash balance minimizes market risks.